Noema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG.
Up To Date
Latest News
After months of lobbying by the BIOM biotech cluster, Bavaria is launching a €50m initiative to push the best...
COVID-19 mRNA vaccine developer Moderna Inc reported it will file for FDA and EMA authorisation of mRNA-1273...
Aviptadil, a vasodilator originally developed to treat erectile dysfunction, led to a 72% survival in...
Polyphor has secured $3.3m from the Cystic Fibrosis Foundation as support for clinical Phase I/IIa testing of...
12 interactive workshops, five plenary sessions and more than 3,000 registered attendees – last week the...